Synthetic biology company founded in 2019 that makes human milk oligosaccharides and single cell protein for food and livestock feed.
Nanjing Yixi Biotechnology, established in 2019, develops synthetic biology technology and products. Its human milk oligosaccharides are used in probiotics and dietary supplements, and its single cell protein, made from straw-based lignocellulose, is used as livestock feed. The company has a 100-acre production plant in Huangshan, Anhui Province, with a capacity of 300 tons per year, and moved to the Suzhou Industrial Park after completing its R&D center in January 2022. In August 2025 it raised nearly CNY 200 million in Series A funding from Huangshan Xinanjiang Capital Investment Management.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in